Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Prostate Cancer Prostatic Dis. 2014 Sep 16;17(4):353–358. doi: 10.1038/pcan.2014.36

Table IV Odds ratios and 95% confidence intervals of BPH for IL10, CRP, and TLR4 haplotypes in the CLUE II cohort of Washington County, Maryland

Haplotype Haplotype frequency OR (95% CI)**

Cases Controls
IL10 N=465 N=472
    A-C-A-C-C-C-A 0.327 0.321 1.00 (Reference)
    T-C-A-C-C-T-G 0.221 0.211 1.04 (0.80-1.34)
    T-C-A-C-C-T-A 0.166 0.145 1.13 (0.86-1.50)
    A-C-A-T-C-C-A 0.125 0.119 1.03 (0.75-1.40)
    A-C-C-T-C-C-A 0.051 0.066 0.73 (0.48-1.11)
         P global †† 0.20

CRP* N=487 N=494
    T-T-T-A 0.342 0.309 1.00 (Reference)
    T-A-T-A 0.313 0.315 0.89 (0.71-1.12)
    C-T-C-A 0.271 0.296 0.83 (0.66-1.04)
    T-T-T-C 0.067 0.070 0.85 (0.59-1.23)
         P global †† 0.57

TLR4 N=351 N=358
    A-T-A-G-G-G-T-C 0.657 0.658 1.00 (Reference)
    G-C-G-A-T-C-C-A 0.130 0.140 0.91 (0.66-1.25)
    G-C-G-A-T-G-T-C 0.107 0.110 0.97 (0.69-1.37)
    G-T-G-G-T-G-T-C 0.061 0.060 1.02 (0.65-1.60)
         P global †† 0.76

TagSNPs: rs1800890, rs1800894, rs3021094, rs1554286, rs3024509, rs3024496, and rs3024498

*

TagSNPs: rs2794521, rs1417938, rs2808630, and rs3093077

TagSNPs: rs2737190, rs10116253, rs1927914, rs1927911, rs2149356, rs7873784, rs11536891, and rs11536898

Haplotypes shown if present in ≥5% of men; haplotypes were missing due to missing genotype for one or more SNPs for IL10 – cases 18.1%, controls 16.9%; CRP – cases 14.3%, controls 13.0%; and TLR4 – cases 18.1%, controls 16.9%.

**

From a generalized linear model using regression substitution adjusted for age.

††

From a global score test of differences in distribution of haplotype frequencies between cases and controls adjusting for age.